To verify whether the high expression of IL-23 in metastasis tumor cells was only the marker for them or it could also promote tumor invasion and migration, we treated HCC cell lines with rhIL-23 as well as knocked down the endogenous IL-23 expression by RNAi. Here, IL37 is linked to hepatocellular carcinoma.